Treatment Refractoriness in Chronic Lymphocytic Leukemia: Old and New Molecular Biomarkers

Nawar Maher, Samir Mouhssine, Bassam Francis Matti, Alaa Fadhil Alwan, Gianluca Gaidano

Open source

DOI
10.3390/ijms241210374
Published
2023-06-20
Container
International Journal of Molecular Sciences
Publisher
MDPI AG
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/ijms241210374,
  title = {Treatment Refractoriness in Chronic Lymphocytic Leukemia: Old and New Molecular Biomarkers},
  author = {Nawar Maher and Samir Mouhssine and Bassam Francis Matti and Alaa Fadhil Alwan and Gianluca Gaidano},
  year = {2023},
  journal = {International Journal of Molecular Sciences},
  doi = {10.3390/ijms241210374},
  url = {https://doi.org/10.3390/ijms241210374}
}

RIS

TY  - JOUR
TI  - Treatment Refractoriness in Chronic Lymphocytic Leukemia: Old and New Molecular Biomarkers
AU  - Nawar Maher
AU  - Samir Mouhssine
AU  - Bassam Francis Matti
AU  - Alaa Fadhil Alwan
AU  - Gianluca Gaidano
PY  - 2023
JO  - International Journal of Molecular Sciences
DO  - 10.3390/ijms241210374
UR  - https://doi.org/10.3390/ijms241210374
ER  - 

APA

Maher, N., Mouhssine, S., Matti, B. F., Alwan, A. F., & Gaidano, G. (2023). Treatment Refractoriness in Chronic Lymphocytic Leukemia: Old and New Molecular Biomarkers. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms241210374

Source records